(Difference between pages)

Page 1

Page 1Revision 1

Page 2

Page 2Revision 2

Content deleted Content addedVisualWikitext

Revision as of 11:58, 5 December 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 459444102 of page Phenacetin for the Chem/Drugbox validation project (updated: 'DrugBank').		Latest revision as of 08:31, 4 January 2025 edit Nardog (talk | contribs)Edit filter helpers, Autopatrolled, Extended confirmed users, New page reviewers, Pending changes reviewers, Rollbackers, Template editors81,677 edits MOS:PRON
Line 1:		Line 1:
			{{Short description|Pharmaceutical drug}}
	{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}}
	{{drugbox		{{drugbox
		⚫	| verifiedrevid = 464199717
	| Verifiedfields = changed
⚫	| verifiedrevid = 459443097
	| IUPAC_name = ''N''-(4-Ethoxyphenyl)acetamide		| IUPAC_name = ''N''-(4-Ethoxyphenyl)acetamide
	| image = Phenacetin.svg		| image = Phenacetin skeletal.svg
			| image2 = Phenacetin molecule ball.png
	<!--Clinical data-->		<!--Clinical data-->
	| pregnancy_category = unknown		| pregnancy_category =
	| legal_status = unknown		| legal_status =
	| routes_of_administration = unknown		| routes_of_administration =
	<!--Pharmacokinetic data-->		<!--Pharmacokinetic data-->
	| bioavailability = unknown		| bioavailability =
	| protein_bound = unknown		| protein_bound =
	| metabolism = unknown		| metabolism =
	| elimination_half-life = unknown		| elimination_half-life =
	<!--Identifiers-->		<!--Identifiers-->
			| IUPHAR_ligand = 7402
	| CASNo_Ref = {{cascite|correct|CAS}}
	| CAS_number_Ref = {{cascite|correct|??}}		| CAS_number_Ref = {{cascite|correct|??}}
	| CAS_number = 62-44-2		| CAS_number = 62-44-2
Line 25:		Line 22:
	| ATC_supplemental =		| ATC_supplemental =
	| PubChem = 4754		| PubChem = 4754
	| DrugBank_Ref = {{drugbankcite|changed|drugbank}}		| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
	| DrugBank = DB03783		| DrugBank = DB03783
	| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}		| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
Line 37:		Line 34:
	| ChEMBL_Ref = {{ebicite|correct|EBI}}		| ChEMBL_Ref = {{ebicite|correct|EBI}}
	| ChEMBL = 16073		| ChEMBL = 16073
	<!--Chemical data-->		<!--Chemical data-->
	| C=10 | H=13 | N=1 | O=2		| C=10 | H=13 | N=1 | O=2
	| molecular_weight = 179.216 g/mol
	| smiles = O=C(Nc1ccc(OCC)cc1)C		| smiles = O=C(Nc1ccc(OCC)cc1)C
	| InChI = 1/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)
	| StdInChI_Ref = {{stdinchicite|correct|chemspider}}		| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
	| StdInChI = 1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)		| StdInChI = 1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)
Line 49:		Line 43:
	| density = 1.24		| density = 1.24
	| melting_point = 134		| melting_point = 134
			| melting_high = 137.5
	| melting_notes = (decomposes)		| melting_notes =
			| solubility = 0.766
			| sol_units = &nbsp;g/L ({{Convert|25|C|F}})
	}}		}}
			'''Phenacetin''' ({{IPAc-en|f|ɪ|ˈ|n|æ|s|ɪ|t|ɪ|n|audio=LL-Q1860 (eng)-Flame, not lame-phenacetin.wav}}; '''acetophenetidin''', '''''N''-(4-ethoxyphenyl)acetamide'''<ref name=canada/>) is a ] and ] drug, which was widely used following its introduction in 1887. It was withdrawn from medicinal use as dangerous from the 1970s (e.g., withdrawn in Canada in 1973,<ref>{{cite web |url=https://www.drugbank.ca/drugs/DB03783 |title=Phenacetin|website=DrugBank|access-date= 28 April 2020}}</ref> and by the ] in 1983<ref>{{cite web|url=https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078577.pdf|archive-url=https://web.archive.org/web/20140930103207/https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/UCM078577.pdf|archive-date=30 September 2014|title=Drugs withdrawn from the market containing phenacetin|date=5 October 1983|publisher=Department of Health and Human Services - FDA}}</ref>).
			==History==
			Phenacetin was introduced in 1887 in ], Germany by German company ], and was used principally as an analgesic; it was one of the first synthetic fever reducers to go on the market. It is also known historically to be one of the first non-] analgesics without anti-inflammatory properties. Although ] (acetaminophen) was produced earlier, a historical accident saw it ignored after ]'s 1893 assessment.<ref name=drugdiscov>{{cite book |title=Drug Discovery: A History | vauthors = Sneader W |publisher=Wiley |year=2005 |isbn=978-0471899808 |page=439 |location=Hoboken, NJ |url=https://books.google.com/books?id=jglFsz5EJR8C&pg=PA439 |url-status=live |archive-url=https://web.archive.org/web/20160818021904/https://books.google.com/books?id=jglFsz5EJR8C&pg=PA439 |archive-date=18 August 2016 |quote=The eminent clinical pharmacologist Joseph von Mering collaborated with the Bayer Company in a trial of paracetamol in 1893. He found it to be an effective antipyretic and analgesic, but claimed it had a slight tendency to produce ]. This could conceivably have been caused by the contamination of his paracetamol with the 4-aminophenol from which it was synthesised.}}</ref>
			Prior to World War One, Britain imported phenacetin from Germany.<ref name="Creese1997" /> During the war, a team including ] and ] developed a synthesis in Britain.<ref name="Creese1997">{{cite journal | vauthors = Creese MR |title=Martha Annie Whiteley (1866-1956): Chemist and Editor |journal=Bulletin for the History of Chemistry |date=1997 |volume=8 |pages=42–45 |url=http://www.scs.illinois.edu/~mainzv/HIST/bulletin_open_access/num20/num20%20p42-45.pdf}}</ref>
			==Known mechanism of action==
			Phenacetin's analgesic effects are due to its actions on the sensory tracts of the spinal cord. In addition, phenacetin has a depressant action on the heart, where it acts as a negative ]. It is an ], acting on the brain to decrease the temperature set point. It is also used to treat ] (subacute type) and intercostal ].
			In vivo, one of two reactions occur. Usually phenacetin's ] is cleaved to leave ] (acetaminophen), which is the clinically relevant analgesic. A minority
			of the time the acetyl group is removed from the amine, producing carcinogenic ]. This reaction is quite rare, however, as evidenced by the fact that the drug was on the market for almost 100 years before a statistical link was established, when Canada, followed by the United States, withdrew it from the market.
			==Preparation==
			The first synthesis was reported in 1878 by ]. Morse's cited article describes the synthesis of paracetamol from 4-aminophenol and acetic acid.<ref>{{cite journal | title = Ueber eine neue Darstellungsmethode der Acetylamidophenole | pages = 232–233 | vauthors = Morse HN | year = 1878 | doi = 10.1002/cber.18780110151 | journal = ] | volume = 11 | issue = 1 | url = https://zenodo.org/record/1425148 }}</ref>
			Phenacetin may be synthesized as an example of the ]: ], ], and anhydrous ] are heated in ] to give the crude product, which is recrystallized from water.<ref>{{cite web | title = Conversion of Acetaminophen into Phenacetin | publisher = ] | work = Chemistry Department Master Experiment Archive | url = http://wwwchem.csustan.edu/archive/Phenacetin.htm | url-status = dead | archive-url = https://web.archive.org/web/20081202111801/http://wwwchem.csustan.edu/archive/Phenacetin.htm | archive-date = 2008-12-02 }}</ref>
			==Uses==
			] cold tablets, containing: ], phenacetin {{Frac|2|1|2}} grs., ], caffeine, ], ], ] complex (U.S. Pat. 2,446,981). That patent number is from 1948; these tablets would have been made shortly thereafter.]]
			=== Medical ===
			Phenacetin was widely used until the third quarter of the twentieth century, often in the form of an A.P.C., or "]-phenacetin-]" ], as a remedy for fever and pain. An early formulation (1919) was ] in Australia.
			In the United States, the ] ordered the withdrawal of drugs containing phenacetin in November 1983, due to its ]ic and kidney-damaging properties.<ref>''Federal Register'' of October 5, 1983 (48 FR 45466)</ref> It was also banned in India.<ref name=ban>{{cite web|url=http://cdsco.nic.in/html/drugsbanned.html|title=Drugs banned in India|publisher=Central Drugs Standard Control Organization, Dte.GHS, Ministry of Health and Family Welfare, Government of India|access-date=2013-09-17|url-status=dead|archive-url=https://web.archive.org/web/20150221053621/http://cdsco.nic.in/html/drugsbanned.html|archive-date=2015-02-21}}</ref> As a result, some branded, and previously phenacetin-based, preparations continued to be sold, but with the phenacetin replaced by safer alternatives. A popular brand of phenacetin was ]'s ], which was reformulated in 1983 to contain ], ] and ]. ] was also reformulated without phenacetin. Paracetamol is a metabolite of phenacetin with similar analgesic and antipyretic effects, but the new formulation has not been found to have phenacetin's carcinogenicity.
			=== Other ===
			Phenacetin has been used as a ] to adulterate ] in the UK and Canada, due to the similar physical properties.<ref>{{cite news | publisher = ] | url = http://news.bbc.co.uk/2/hi/uk_news/6178026.stm | title = Cancer chemical in street cocaine | date= 23 November 2006}}</ref> There, it has been given the nickname "magic".
			Due to its low cost, phenacetin is used for research into the physical and refractive properties of crystals. It is an ideal compound for this type of research.{{why|date=January 2021}}<ref name=canada>{{cite journal | vauthors = Gralak B, Enoch S, Tayeb G | title = Anomalous refractive properties of photonic crystals | journal = Journal of the Optical Society of America A| volume = 17 | issue = 6 | pages = 1012–1020 | date = June 2000 | pmid = 10850471 | doi = 10.1364/JOSAA.17.001012 | citeseerx = 10.1.1.462.8012 | bibcode = 2000JOSAA..17.1012G }}</ref><ref>{{Cite journal | url=http://www.turpion.org/php/paper.phtml?journal_id=qe&paper_id=556 | doi = 10.1070/QE1995v025n12ABEH000556 | title = GdVO4as a new medium for solid-state lasers: Some optical and thermal properties of crystals doped with Cd3+, Tm3+, and Er3+ions | journal = Quantum Electronics | volume = 25 | issue = 12 | pages = 1162–1165 | year = 1995 | vauthors = Studenikin PA, Zagumennyi AI, Zavartsev YD, Popov PA, Shcherbakov IA | s2cid = 250787020 }}</ref>
			In Canada, phenacetin is used as a laboratory reagent, and in a few hair dye preparations (as a stabilizer for hydrogen peroxide). While it is considered a prescription drug, no marketed drugs contain phenacetin.<ref>{{cite web |url=https://www.canada.ca/en/health-canada/services/chemical-substances/fact-sheets/chemicals-glance/phenacetin.html |title=Health - Product safety - Chemical substances - Phenacetin information sheet|website=Government of Canada - |date=18 April 2017|access-date= 29 April 2020}}</ref>
			==Safety==
			Phenacetin, and products containing phenacetin, have been shown in an ] to have the side effect and after-effect of ]. In humans, many case reports have implicated products containing phenacetin in urothelial neoplasms, especially ] of the ]. Phenacetin is classified by the ] (IARC) as carcinogenic to humans.<ref name=canada/> In one prospective series, phenacetin was associated with an increased risk of death due to urologic or renal diseases, death due to cancers, and death due to cardiovascular diseases.<ref>{{cite journal | vauthors = Dubach UC, Rosner B, Stürmer T | title = An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987) | journal = The New England Journal of Medicine | volume = 324 | issue = 3 | pages = 155–160 | date = January 1991 | pmid = 1984193 | doi = 10.1056/NEJM199101173240304 | doi-access = free }}</ref>
			In addition, people with ] may experience acute ], or dissolution of blood cells, while taking this drug. Acute hemolysis is possible in the case of patients who develop an ] response to phenacetin leading to immune complexes that bind to ] in blood. The erythrocytes are then lysed when the complexes activate the ].
			Chronic use of phenacetin is known to lead to ] characterized by ].<ref>{{cite journal | vauthors = Cochran AJ, Lawson DH, Linton AL | title = Renal papillary necrosis following phenacetin excess | journal = Scottish Medical Journal | volume = 12 | issue = 7 | pages = 246–250 | date = July 1967 | pmid = 6036245 | doi = 10.1177/003693306701200702 | s2cid = 33774826 }}</ref><ref>{{cite journal | vauthors = Tan GH, Rabbino MD, Hopper J | title = Is Phenacetin a Nephrotoxin?: A Report on Twenty-three Users of the Drug | journal = California Medicine | volume = 101 | issue = 2 | pages = 73–77 | date = August 1964 | pmid = 14180501 | pmc = 1515485 }}</ref><ref>{{cite journal | vauthors = Brix AE | title = Renal papillary necrosis | journal = Toxicologic Pathology | volume = 30 | issue = 6 | pages = 672–674 | year = 2002 | pmid = 12512867 | doi = 10.1080/01926230290166760 | doi-access = free }}</ref> This is a condition which results in destruction of some or all of the ]e in the kidneys. It is believed that the metabolite ] is at least partly responsible for these effects.<ref name=Kankuri>{{cite journal | vauthors = Kankuri E, Solatunturi E, Vapaatalo H | title = Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro | journal = Thrombosis Research | volume = 110 | issue = 5–6 | pages = 299–303 | date = June 2003 | pmid = 14592552 | doi = 10.1016/S0049-3848(03)00416-X }}</ref>
			One notable death that can possibly be attributed to the use of this drug was that of the aviation pioneer ]. He had been using phenacetin extensively for the treatment of ]; it was stated during his autopsy that phenacetin use may have been the cause of his ].<ref>{{cite journal | vauthors = Tennant F |date=July{{ndash}}August 2007 |title=Howard Hughes & Pseudoaddiction |url=http://www.foresttennant.com/pdfs/HowardHughes.pdf |journal=Practical Pain Management |volume=7 |issue=6 |page=20 |access-date=2 November 2015 |quote=The phenacetin in the codeine compound produced, over time, kidney failure and death. |url-status=dead |archive-url=https://web.archive.org/web/20150924014602/http://www.foresttennant.com/pdfs/HowardHughes.pdf |archive-date=24 September 2015 }}</ref>
			== In popular culture ==
			A 1974 episode of the ] series ], "Duty of Care", features a court case that resulted from a woman dying of phenacetin poisoning, as a result of taking A.P.C. for five years. This explained that phenacetin caused renal papillary necrosis.<ref>{{Cite AV media |title=Duty of Care |work=] |date=31 May 1974 |publisher=] }}</ref>
			In the book '']'' chapter 4, "APCs for headaches" is included in a list of valuable things to take on motorcycle trips.<ref>{{Cite book |last1=Pirsig |first1=Robert M. |date=1985 |publisher=Bantam |edition=82nd printing |title=Zen and the Art of Motorcycle Maintenance |page=35}}</ref>
			== See also ==
			* ]
			== References ==
			{{Reflist}}
			== External links ==
			{{wiktionary}}
			*
			*
			* {{Webarchive|url=https://web.archive.org/web/20060924185947/http://physchem.ox.ac.uk/MSDS/PH/phenacetin.html |date=2006-09-24 }}
			{{Analgesics}}
			{{Prostanoidergics}}
			]
			]
			]
			]
			]
			]
			]
			]